Experts want to know why the agency approved a questionable Alzheimer’s drug but has withheld full approval from Covid vaccines.

Six months into Biden’s presidency, the FDA is in turmoil; the administration still hasn’t even named a commissioner to lead the agency. The hasty Aduhelm approval shocked observers, in part because the agency has yet to offer full approval to Covid-19 vaccines despite millions of successful and safe vaccinations. With Pfizer expected to file within weeks for another emergency use authorization for a third Covid booster shot, and the highly contagious delta variant spreading, fully approving the Covid vaccines could offer the country a much-needed vaccination boost. “The FDA is close to hitting rock bottom,” Dr. Gregg Gonsalves, a professor at Yale’s School of Public Health, said. Read more at The New Republic.